Overview of Zika Virus Testing -- Overview of Updates to Testing Guidance -- Biological Safety -- Testing Methods -- Detailed Information for Specimen Types for Zika Testing -- Reporting -- References -- Table 1. Interpretation of results of nucleic acid and antibody testing for suspected Zika virus infection — United States, 2017 -- Table 2. Interpretation of results of nucleic acid and antibody testing for suspected Zika virus infection in non- pregnant individuals — United States, 2017 -- Figure 1. Testing Recommendations for Symptomatic Non-Pregnant Individuals with Exposure to Zika Virus.

Current guidance for US laboratories testing for Zika virus infection (https://www.cdc.gov/zika/laboratories/lab-guidance.html) recommends that testing be limited to specimens collected from patients meeting CDC’s clinical and/or epidemiologic criteria for testing (http://www.cdc.gov/zika/symptoms/index.html; http://www.cdc.gov/zika/hc-providers).1 Clinical signs and symptoms associated with Zika virus infection are discussed here: http://www.cdc.gov/zika/symptoms. Current Zika information and guidance is available on CDC’s Zika website at http://www.cdc.gov/zika. Information specific to laboratories is available at http://www.cdc.gov/zika/laboratories.

Current information and guidance specific to Zika virus in Puerto Rico can be found on the Puerto Rico Department of Health website: http://www.salud.gov.pr/Sobre-tu-Salud/Pages/Condiciones/Zika.aspx.

Stephen B. Thacker CDC Library collection